Using the mouse Nphs1 promoter, which is highly specific within kidney for podocytes, allowed targeting of APOL1-transgene expression to the cell where APOL1 is expressed in human kidneys and from where it is thought to drive APOL1-mediated kidney disease. Here, APOL1 is linked to kidney disorder.